- Stocks Telegraph
- Posts
- 9 May - ST - Morning Newsletter (with survey at top and bottom)
9 May - ST - Morning Newsletter (with survey at top and bottom)
4 Stocks Rallying in Today's Down Market
The Newsheater daily morning newsletter is powered by Stocks Telegraph
Help us improve newsletter by taking
Good Morning!
US stock futures started the week in the red, while government bond yields hit new multi-year highs. Investors are concerned that further interest rate hikes and China's containment measures against Covid-19 will weigh on economic growth.Futures for the S&P 500 index fell 1.3%, which promises another day of decline for the broad US market. Futures on the Nasdaq-100 tech index fell 1.5%, while contracts on the Dow Jones Industrial Average fell 1.3%.The US government bond market again saw a sell-off, bringing the 10-year Treasury yield to 3.195% versus 3.124% on Friday. It is likely that the yield at the end of the day will update a multi-year high. Since the end of 2021, 10-year bond yields have risen by 1.6 percentage points, prompting some investors to reassess the value of technology and growth stocks
$2 Small-Cap Uranium Stock Set for Big Gains in 2022 Bull Run
Small-cap Uranium stocks are soaring. Most have already doubled as Uranium cranks higher. But that's nothing compared to the gains ahead in the new Uranium bull market. The last time we saw something like this, well-positioned investors made 10X, 100X and up to 1,000X their money. We've uncovered the top $2 Uranium stock for 2021-22 riches.
Today Top Movers
Mereo BioPharma Group plc (MREO) stock soared 13.38% to $0.6601 in the pre-market trading after announcing positive top-line efficacy and safety results from “ASTRAEUS”.
Better Therapeutics Inc. (NASDAQ: BTTX) shares are trading up 9.57% at $2.06 at the time of writing. The company reported that it will release its first-quarter 2022 financial results before the market opens on Friday, May 13, 2022.
PepGen Inc. (PEPG) grew over 16.37% at $15.00 in pre-market trading today. The company recently announced the pricing of its initial public offering.
Palisade Bio, Inc. (PALI), a biotechnology company, jumped about 11.95% at $0.57 in pre-market trading Monday after declaring $2.0 million registered direct offering
One company perfectly positioned for the EV shift
While the prices for lithium and nickel skyrocket in anticipation of the electric vehicle revolution, one overlooked company is perfectly positioned to capitalize.
Top Upgrades & Downgrades
New Street Research turned bullish on DLocal Limited (DLO), upgrading the stock to "Buy" and assigning a $38.00 price target, representing potential upside of 90% from Friday's close.
Cigna Corporation (CI) has won the favor of Cowen & Co.'s equity research team. The firm upgraded the shares from Market Perform to Outperform and moved their price target to $329.00, suggesting 23.32% additional upside for the stock.
Prestige Consumer Healthcare Inc. (PBH) received an upgrade from analysts at Oppenheimer, who also set their one-year price target on the stock to $63.00. They changed their rating on PBH to Outperform from Perform in a recently issued research note.
Earlier Monday Piper Sandler reduced its rating on BankUnited Inc. (BKU) stock to Underweight from Neutral and assigned the price target to $41.00.
JP Morgan analysts reduced their investment ratings, saying in research reports covered by the media that its rating for iHeartMedia Inc. (IHRT) has been changed to Neutral from Overweight and the new price target is set at $19.00.
Analysts at Credit Suisse downgraded DISH Network Corporation (DISH)'s stock to Neutral from Overweight Monday.
#1 Gold Royalty Stock in New Gold Bull Market Revealed
The New Gold Bull Market is officially here! Gold just blew past $1,900 and the Smart Money is now flowing into a newly-listed US$4 gold stock that brilliantly receives a cut of global gold production without ANY of the risks, or costs, of operating a mine.
Latest Insider Activity
Apple Inc. (AAPL) SVP, GC and Secretary Adams Katherine L. announced the sale of shares taking place on May 04 at $161.72 for some 25,000 shares. The total came to more than $4,042,888.
Twitter Inc. (TWTR) Chief Accounting Officer Kaiden Robert sold on May 05 a total 17,695 shares at $50.50 on average. The insider’s sale generated proceeds of almost $893,598.
Rocket Companies Inc. (RKT) Chief Executive Officer Farner Jay declared the purchase of shares taking place on May 06 at $8.48 for some 23,500 shares. The transaction amount was around $199,280.
Signify Health Inc. (SGFY) Pres. Chief Fin. & Admin. Off. Senneff Steve bought on May 06 a total 10,000 shares at $12.55 on average. The purchase cost the insider an estimated $125,535.
Forbes mag says this strategy "like finding money in the street"
And Reuters magazine calls this type of trading "the new baby boomer hobby." An anonymous trader -- living at the base of the Smoky Mountains -- just released a free report revealing a step-by-step system to generating an extra $5,000 per month in income thanks to this trading strategy. The report is free until Sunday.
Important Earnings
Top US earnings releases scheduled for today include Palantir Technologies Inc. (NYSE:PLTR). It will announce its Mar 2022 financial results. The company is expected to report earnings of $0.04 per share from revenues of $443.42M in the three-month period.
Analysts expect Viatris Inc. (NASDAQ: VTRS) to report a net income of $0.83 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Mar 2022 is predicted to come in at $4.23B.
Elanco Animal Health Incorporated (ELAN), due to announce earnings before the market opens today, is expected to report earnings of $0.35 per share from revenues of $1.22B recently concluded three-month period.
That's it for today. Thanks for reading. Good luck out there!Best Regards,Stocks Telegraph Team
P.S. Want my daily watchlists sent to your cell phone too? Just go HERE and join my text message list!
Wouldn’t it be great to have a personalized solution for your investing needs? We’re adding new sections to the morning newsletter with big implications. All you have to do is share your thought about the current newsletter. If you do that, we’ll do our best to take your feedback and make it a better experience for you.
We are asking for 1 minute of your time to answer 4 questions about your experience with our newsletter. We hope to use this information to create solutions that address exactly what you need!
Thank you for your continued support.
Disclaimer: Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.